Document Type

Article

Publication Date

August 2021

Patent Number

11078235

Abstract

The present invention concerns cyclic compounds, compositions comprising the cyclic compounds, linkers, a method of preparing a carrying agent:cyclic compound adduct, a method for treating disorders such as proliferation disorders (e.g., malignancies), bone deficiency diseases, and autoimmune diseases, and a method for suppressing the growth of, or inducing apoptosis in, cells (e.g., malignant cells).

Application Number

16/025382

Assignees

H. Lee Moffitt Cancer Center And Research Institute, Inc.

Filing Date

07/02/2018

Share

COinS